T0	Participants 208 222	COPD patients.
T1	Participants 1077 1083	study.
T2	Participants 1084 1177	Participants can use any background treatment for COPD except inhaled anticholinergic agents.
T3	Participants 1178 1235	The study encompasses a wide range of COPD patients, e.g.
T4	Participants 1236 1311	patients with stable cardiac diseases including arrhythmia can be included.
T5	Participants 1312 1397	Clinical sites are international and include both primary care as well as specialists
T6	Participants 1399 1498	RESULTS To date, over 17,000 participants have been randomized from over 1200 sites in 50 countries